SCHEDULE 13G

Company

Immunome Inc.

Filed

January 13, 2021

Accession Number

0000899140-21-000055

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →